Great Point to make ~5x return on Clinical Supplies Management sale

Great Point Partners, Clinical Supplies Management, healthcare, clinical trial, private equity, merger, m&a
skynesher/E+/Getty Images
Less than two years into its investment, Great Point Partners is poised to generate a 4.9x return by selling Clinical Supplies Management, a source familiar with the matter said. The buyer is U.K. pharmaceutical services company Clinigen, which has agreed ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.